FIELD: medicine; veterinary medicine.
SUBSTANCE: invention refers to heterocyclic compound specifically to application of 2-imidozolylpropan-2-sulphacid formula: as bacteristatic, immunostimulating, antiaggregatory, thrombocytes deaggregatingagent stimulating contractive activity of skeletal muscles.
EFFECT: more wide application of combination for medicine and veterinary medicine.
1 cl, 9 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING 2-IMIDAZOLYLPROPANE-2-SULFOACID | 2006 |
|
RU2312103C1 |
3-METHYL-8-PIPERAZINE-7-(THIETHANYL-3)-1-ETHYLXANTHINE HYDROCHLORIDE, EXHIBITING ANTIAGGREGANT AND DISAGGREGATION ACTIVITY | 2009 |
|
RU2404181C1 |
2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
ANTIAGGREGANT | 2005 |
|
RU2353363C2 |
USE OF PINANYLSULFIDE WITH METHYL MERCAPTOACETATE FRAGMENT - METHYL 2-({[(1S,2R,5S)-6,6-DIMETHYLBICYCLO[3.1.1]HEPT-2-YL]METHYL}THIO) ACETATE, AS AN AGENT WITH INHIBITORY EFFECT ON PLATELET ACTIVATION | 2015 |
|
RU2671567C2 |
METHOD FOR STUDYING ANTI-AGGREGATION ACTION OF PREPARATIONS BY DETERMINING BLOOD PLATELET AGGREGATION IN VITRO | 2000 |
|
RU2188419C2 |
5-(4'-HYDROXYPHENYL)-AND 5-(2',5'-DIHYDROXYPHENYL)-6 H-1,3,4-THIADIAZINE-2-AMINES, HYDROHALOGENIDES INHIBITING THROMBOCYTE AGGREGATION IN INTRAVENOUS INTRODUCTION | 2009 |
|
RU2458060C2 |
METHOD FOR ASSESSING HEMOSTATIC ACTIVITY | 2015 |
|
RU2601111C1 |
METHOD FOR PREVENTING THROMBOSIS AND EMBOLISM | 2002 |
|
RU2241464C2 |
AGENT SHOWING ANTIAGGREGATION ACTIVITY | 1990 |
|
RU2033791C1 |
Authors
Dates
2008-05-27—Published
2006-04-20—Filed